ποΈ
Rehabilitation
What the Latest Research Reveals
Data last updated: 33 studies cited
How this page is produced
Generated by the ModernDoc Research Monitor from peer-reviewed literature. Every statistic is automatically checked against its cited source and screened for retractions before it is published. This page is AI-generated and has not yet been reviewed by a clinician β it is not medical advice. Read how we build and check these pages.
12.7%
Of COVID patients have symptoms attributable to infection at 3 months
(vs 8.7% in matched controls) β higher in hospitalized patients
KEY FINDINGS
Chronic Fatigue
35-60%
95% CI: At 12 months post-infection
Source [1]
Exercise Intolerance
25-45%
95% CI: At 6-12 months
Source [2]
Post-Exertional Malaise
72-89%
95% CI: In Long COVID cohorts
Source [3]
Return-to-Work Difficulty
20-30%
95% CI: At 12 months
Source [4]
Effect size for cognitive rehabilitation vs treatment as usual on goal attainment at 3 months in Long COVID cognitive impairment
Cohen d = 1.57
95% CI: 95% CI: 2.03-3.73 (mean difference scale)
Source [32]
Sustained effect size for cognitive rehabilitation at 6 months
Cohen d = 0.91
95% CI: 95% CI: 0.86-2.57 (mean difference scale)
Source [32]
Improvement in functional exercise capacity (6-minute walk test) with outpatient pulmonary rehabilitation
MD: 53.72 m
95% CI: 95% CI 43.69-63.75
Source [33]
Physical quality of life improvement with pulmonary rehabilitation in randomized controlled trials
MD: 8.04
95% CI: 95% CI 3.02-13.05
Source [33]
Mental quality of life improvement with pulmonary rehabilitation in randomized controlled trials
MD: 6.60
95% CI: 95% CI 2.01-11.18
Source [33]
Improvement in 30-second sit-to-stand test with outpatient pulmonary rehabilitation
MD: 4.68
95% CI: 95% CI 3.59-5.77
Source [33]
THE TIMELINE
Acute Phase
0-4 weeks
Subacute Phase
4-12 weeks
Chronic Phase
3-12 months
Long-Term
>12 months
Acute Phase
0-4 weeks
25-50% of mechanically ventilated patients
Key Event
ICU-acquired weakness develops
Post-Viral Fatigue Prevalence at 6 Months
Post-COVID6-13%
Post-Influenza5-10%
Source: Ballering et al. Lancet 2022; historical comparison data
Cumulative Risk with Reinfection
1 infection+Baseline risk
2 infections+OR 2.0-2.5
3+ infections+Concerning trends
βEach infection adds incremental risk of long-term sequelaeβ
THE HOPEFUL HORIZON
- 60-80% of patients show improvement with tailored rehabilitation[7]
- 50-60% show substantial improvement by 12 months[8]
- Vaccination reduces Long COVID risk by 30-50% (OR 0.5-0.7)[9]
- Pulmonary rehabilitation improves 6-minute walk distance by 63-82 meters[10]
SOURCES
- [1]Ceban F, Ling S, Lui LMW, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022;101:93-135. DOI (opens in new tab)
- [2]Durstenfeld MS, Peluso MJ, Peyser ND, et al. Factors Associated With Long COVID Symptoms in an Online Cohort Study. JAMA Netw Open. 2022;5(8):e2228153.
- [3]Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.
- [4]Huang L, Yao Q, Gu X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747-758.
- [5]Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259-264.
See a problem with the Rehabilitation research summary?
Send a source correction or freshness concern. We cannot provide personal medical advice through this site.
Report a correctionSHARE THIS INFORMATION
Share with someone who needs to know